Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoglycemia in type 2 diabetes.

Salomon Banarer1, Philip E Cryer

  • 1Department of Medicine, University of Louisville, ACB 3rd Floor, Suite 83G11, 550 Jackson Street, Louisville, KY 40209, USA.

The Medical Clinics of North America
|August 17, 2004
PubMed
Summary

Iatrogenic hypoglycemia, often caused by insulin therapy, hinders diabetes management. Reducing hypoglycemia risks and improving glucose counterregulation are key to better glycemic control in type 2 diabetes mellitus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individualized Glycemic Goals and an Expanded Classification of Severe Hypoglycemia in Diabetes.

Diabetes care·2017
Same author

Dissociation Between Hormonal Counterregulatory Responses and Cerebral Glucose Metabolism During Hypoglycemia.

Diabetes·2017
Same author

Hypoglycemia-Associated Autonomic Failure in Diabetes: Maladaptive, Adaptive, or Both?

Diabetes·2015
Same author

Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia.

Diabetes·2014
Same author

Lactate and the mechanism of hypoglycemia-associated autonomic failure in diabetes.

Diabetes·2013
Same author

Hypoglycemia-associated autonomic failure in diabetes.

Handbook of clinical neurology·2013

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Management

Background:

  • Iatrogenic hypoglycemia is a significant clinical challenge in managing diabetes, particularly in advanced type 2 diabetes mellitus.
  • Hypoglycemia in these patients arises from excessive therapeutic insulin combined with diminished physiological and behavioral defenses against low blood glucose.
  • This complication impedes achieving optimal glycemic control and impacts patient quality of life.

Purpose of the Study:

  • To highlight the clinical problem of iatrogenic hypoglycemia in advanced type 2 diabetes mellitus.
  • To discuss the mechanisms contributing to hypoglycemia in insulin-treated diabetic patients.
  • To emphasize the need for strategies to minimize hypoglycemia risk and improve overall glycemic management.

Main Methods:

  • Review of clinical literature and established understanding of diabetes pathophysiology.
  • Analysis of factors contributing to hypoglycemia in type 2 diabetes mellitus.
  • Discussion of risk reduction strategies and glycemic control principles.

Main Results:

  • Iatrogenic hypoglycemia is a primary limitation in achieving effective glycemic management for diabetes.
  • The risk increases as type 2 diabetes progresses towards insulin deficiency.
  • Effective management involves a combination of hypoglycemia risk reduction and aggressive glycemic therapy.

Conclusions:

  • Minimizing hypoglycemia risk is achievable through proactive strategies and understanding patient-specific factors.
  • Improved glucose counterregulation and risk factor consideration are crucial for safe and effective diabetes care.
  • There is an ongoing need for enhanced treatment regimens to better manage diabetes while avoiding hypoglycemia.

Related Experiment Videos